PTC Therapeutics (NASDAQ:PTCT) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
PTC Therapeutics missed estimated earnings by 23.78%, reporting an EPS of $-2.03 versus an estimate of $-1.64.
Revenue was up $46.36 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.49 which was followed by a 4.09% increase in the share price the next day.
Here's a look at PTC Therapeutics's past performance:
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
